HIF1A and hepatocellular carcinoma: Furthermore, increased HIF-1α activity in HCC samples has been associated with worse overall survival rates and lower response to external beam radiotherapy, thus suggesting HIF-1α as a predictive biomarker of treatment outcomes [63].